Synonyms:acetohexamide, 968-81-0, Dymelor, Acetohexamid, Gamadiabet, Dimelor, Hypoglicil, Metaglucina, Tsiklamid, Minoral, Ordimel, Acetohexamida, Acetohexamidum, 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea, N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea, 1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea, 4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide, NCI-C03247, 1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea, U-14812, 4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide, Benzenesulfonamide, 4-acetyl-N-[(cyclohexylamino)carbonyl]-, NSC-759128, QGC8W08I6I, Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-, 3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea, DTXSID7020007, CHEBI:28052, Acetohexamide [USAN), NCGC00015014-05, CAS-968-81-0, 1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea, DTXCID707, 1-[(p-Acetylphenyl)sulfonyl]-3-cyclohexylurea, ACETOHEXAMIDE [USAN], 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide, Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl-, Urea, 1-[(p-acetylphenyl)sulfonyl]-3-cyclohexyl-, Acetohexamidum [INN-Latin], Acetohexamida [INN-Spanish], CCRIS 4, Dymelor (TN), HSDB 3280, SR-01000075539, EINECS 213-530-4, U 14812, UNII-QGC8W08I6I, BRN 2225115, N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea, Prestwick_3, 3-aminomethylbenzamide, 4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide, Acetohexamide [USAN:USP:INN:BAN:JAN], Lopac-A-178, Prestwick0_000055, Prestwick1_000055, Prestwick2_000055, Prestwick3_000055, A-178, ACETOHEXAMIDE [MI], ACETOHEXAMIDE [INN], ACETOHEXAMIDE [JAN], ACETOHEXAMIDE [HSDB], CHEMBL1589, Lopac0_000088, SCHEMBL37620, ACETOHEXAMIDE [VANDF], BSPBio_000209, MLS002154186, ACETOHEXAMIDE [MART.], SPBio_002130, ACETOHEXAMIDE [WHO-DD], BPBio1_000231, GTPL6793, Acetohexamide (JP17/USP/INN), Acetohexamide, analytical standard, HMS1568K11, HMS2093H21, HMS2095K11, HMS2236M07, HMS3260A18, HMS3372B02, HMS3712K11, Pharmakon1600-01505425, ACETOHEXAMIDE [ORANGE BOOK], BCP34666, HY-B0881, ACETOHEXAMIDE [USP IMPURITY], Tox21_110067, Tox21_202022, Tox21_302735, Tox21_500088, NSC759128, s5717, AKOS015916290, Tox21_110067_1, CCG-204183, DB00414, LP00088, NSC 759128, SDCCGSBI-0050076.P003, NCGC00015014-01, NCGC00015014-02, NCGC00015014-03, NCGC00015014-04, NCGC00015014-06, NCGC00015014-07, NCGC00015014-08, NCGC00015014-11, NCGC00015014-15, NCGC00016555-01, NCGC00091230-01, NCGC00091230-02, NCGC00091230-03, NCGC00091230-04, NCGC00256467-01, NCGC00259571-01, NCGC00260773-01, MS-24845, SMR001233477, SBI-0050076.P002, DB-057652, EU-0100088, FT-0661053, C06806, D00219, EN300-123648, F85186, 1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea, A845651, A935756, Dymelor; Gamadiabet; Acetohexamid; Dimelin; Dimelor, Q4673274, SR-01000075539-1, SR-01000075539-3, SR-01000075539-6, 4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide, BRD-K52960356-001-03-1, BRD-K52960356-001-06-4, Z1552195936, 1-Acetyl-4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)benzene #, Acetohexamide, United States Pharmacopeia (USP) Reference Standard, BENZENESULFONAMIDE, 4-ACETYL-N-((CYCLOHEXYLAMINO)CARBONYL), 1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide
Pubchem:PUBCHEM:1989
Id:99210b46-6655-5d7e-a409-06134cc3b867
Description:nan
